EASST Fellow Dr. Jeanine Condo, Director General of the Rwanda Biomedical Center, was recently quoted in The New Times article announcing the recent launch of a new mosquito insecticide, Acstelli, kicking off the official use of indoor residual spraying in Rwanda.
The Rwanda Biomedical (RBC) has created a newly mosquito insecticide, Acstelli, sparking the official usage of indoor residual spraying in the country in hopes of providing a sustainable and rational deployment of effective malaria vector control tools in order to save lives and improve health nationally.
It is expected that by the end of the year, eight malaria prone districts in the country will have been sprayed with insecticide. Director-General of RBC, Dr. Jeanine Condo noted other options and programs to fight malaria beyond the tool of indoor residual spraying: Before the year ends, around six million high-lasting insecticide treated mosquito nets will be distributed throughout the country.
To read the original article, go here.